Lexicon Pharmaceuticals LXRX Operating Lease Weighted Average Discount Rate Percent
Operating Lease Weighted Average Discount Rate Percent at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's operating lease weighted average discount rate percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's operating lease weighted average discount rate percent?
- Lexicon Pharmaceuticals (LXRX) reported operating lease weighted average discount rate percent of $0.11 in Q1 2026.
- How has Lexicon Pharmaceuticals's operating lease weighted average discount rate percent changed year-over-year?
- Lexicon Pharmaceuticals's operating lease weighted average discount rate percent increased by 8.2% year-over-year, from $0.1 to $0.11.
- What is the long-term trend for Lexicon Pharmaceuticals's operating lease weighted average discount rate percent?
- Over 3 years (2022 to 2025), Lexicon Pharmaceuticals's operating lease weighted average discount rate percent has grown at a 3.0% compound annual growth rate (CAGR), from $0.1 to $0.11.